RBC Capital Remains a Hold on Pliant Therapeutics (PLRX)
at www.tipranks.com (Fri, 13-Nov 11:56 AM)
Pliant Therapeutics GAAP EPS of -$0.39 misses by $0.02
at seekingalpha.com (Thu, 12-Nov 5:22 PM)
PLRX Wins FDA Fast Track for PLN-101095 Combo in Hard-to-Treat Solid Tumors
Market Chameleon (Tue, 18-Aug 11:08 AM)